We evaluated the expression of NKp30, NKp44, NKp46, and NKG2D in NK-92 cells co-cultured with HeLa, SiHa, and C-33A cancer cells pre-treated or not with the HO-1 inhibitors. The gene discussed is NCR2; the disease is cancer.